Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | Accessibility of CAR-T and the move from specialist centers

Charalambos Andreadis • 10 Dec 2023
ASH 2023
General CAR-T

Charalambos Andreadis, MD, MSCE, UCSF Health, San Francisco, CA, briefly discusses the accessibility challenges faced with CAR T-cell therapy, as this treatment option is only available in specialist centers. Dr Andreadis hopes that with advances in the field, CAR-T will become accessible to a greater proportion of patients. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consultancy: Kite/Gilead, BMS, Novartis; Grants or contracts: BMS, Novartis, Genentech; Research Funding: Merck & Co., Inc.

More from Charalambos Andreadis

0:49
Treating DLBCL with CAR-T: the best candidates and selecting a CAR-T product
Charalambos Andreadis • 10 Dec 2023
1:09
Ibrutinib added to autoSCT conditioning and consolidation for patients with ABC-DLBCL
Charalambos Andreadis • 10 Dec 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals